Circulating levels of amyloid-beta (1-40) peptide associate with cardiometabolic traits and risk for metabolic dysfunction-associated steatotic liver disease

13 April 2024 (00:00 - 00:00)
Organised by: Logo
Congress Presentation Part of: Targets and markers of cardiometabolic disease Biomarkers CBS PREMIUM ACCESS Frontiers in CardioVascular Biomedicine 2024 Council on Basic Cardiovascular Science